Oscar Health, Inc., a prominent health insurance company based in New York, recently disclosed its latest quarterly financial results, reflecting the company’s ongoing efforts to innovate within the healthcare sector. As of February 11, 2026, the company reported a closing stock price of $13.67 in the most recent trading session. This figure is part of a broader trend observed over the past year, where the stock price has experienced significant fluctuations, reaching a low of $11.20 on April 20, 2025, and a peak of $23.80 on October 6, 2025.
Oscar Health’s mission centers on transforming the healthcare industry through a technology-driven approach. The company leverages a sophisticated platform that utilizes personalized data to provide real-time, actionable insights and recommendations. This includes guiding members to appropriate healthcare providers, such as doctors and hospitals, thereby enhancing the overall healthcare experience.
Despite its innovative approach, Oscar Health’s financial metrics present a mixed picture. The company’s market capitalization stands at approximately $4.07 billion USD, reflecting its substantial presence in the financial sector. However, the company’s valuation metrics reveal some challenges. Notably, the price-to-earnings (P/E) ratio is currently negative at -8.08, indicating that the company is not yet profitable. This negative P/E ratio suggests that investors are valuing the company based on future growth potential rather than current earnings.
Additionally, the price-to-book (P/B) ratio of 4.15 indicates that the stock is trading above its book value. This metric often suggests that investors have high expectations for the company’s future performance and growth prospects, despite the current lack of profitability.
Oscar Health’s strategic focus on leveraging technology to enhance healthcare delivery remains a key differentiator in the competitive insurance landscape. As the company continues to navigate its financial challenges, its commitment to innovation and personalized healthcare solutions positions it as a noteworthy player in the financials sector, particularly within the health insurance industry.
